Exagen Statistics
Share Statistics
Exagen has 22M
shares outstanding. The number of shares has increased by 25.73%
in one year.
| 22M |
| 25.73% |
| 22.14% |
| 33.61% |
| 14.75M |
| 100 |
| 0.03% |
Short Selling Information
The latest short interest is 551.62K, so 2.51% of the outstanding
shares have been sold short.
| 551.62K |
| 2.51% |
| 3.07% |
| 2.78 |
Valuation Ratios
The PE ratio is -4.94 and the forward
PE ratio is -25.34.
Exagen's PEG ratio is
0.13.
| -4.94 |
| -25.34 |
| 1.34 |
| 2.8 |
| 7.82 |
| -5.41 |
| 0.13 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Exagen.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.7,
with a Debt / Equity ratio of 2.45.
| 2.7 |
| 2.7 |
| 2.45 |
| -2.1 |
| -1.69 |
| -6.1 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $266.22K |
| $-72.32K |
| 209 |
| 1.25 |
| n/a |
Taxes
| 12K |
| -0.08% |
Stock Price Statistics
The stock price has increased by 229.05% in the
last 52 weeks. The beta is 1.6, so Exagen's
price volatility has been higher than the market average.
| 1.6 |
| 229.05% |
| 8.59 |
| 5.83 |
| 62.74 |
| 298,311 |
Income Statement
In the last 12 months, Exagen had revenue of 55.64M
and earned -15.12M
in profits. Earnings per share was -0.83.
| 55.64M |
| 33.11M |
| -13.64M |
| -15.12M |
| -11.14M |
| -12.87M |
| -0.83 |
Full Income StatementBalance Sheet
The company has 22.04M in cash and 23.36M in
debt, giving a net cash position of -1.33M.
| 22.04M |
| 23.36M |
| -1.33M |
| -294.33M |
| 58.76M |
| 40.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -13.28M
and capital expenditures -515K, giving a free cash flow of -13.79M.
| -13.28M |
| -515K |
| -13.79M |
| -0.76 |
Full Cash Flow StatementMargins
Gross margin is 59.51%, with operating and profit margins of -24.51% and -27.17%.
| 59.51% |
| -24.51% |
| -27.14% |
| -27.17% |
| -20.03% |
| -24.51% |
| -24.79% |
